Correia Fábio Pereira, Coelho Henrique, Francisco Mónica, Alexandrino Gonçalo, Branco Joana Carvalho, Canena Jorge, Horta David, Lourenço Luís Carvalho
Gastroenterology Department, Hospital Prof. Dr. Fernando Fonseca, Amadora 2720-276, Portugal.
Gastroenterology Department, Hospital Prof. Dr. Fernando Fonseca, Amadora 2720-276, Portugal.
Clin Res Hepatol Gastroenterol. 2025 Jan;49(1):102515. doi: 10.1016/j.clinre.2024.102515. Epub 2024 Dec 13.
Endoscopic retrograde cholangiopancreatography (ERCP) is the first-line procedure for choledocholithiasis treatment. However, it is associated with a 10 % rate of adverse events. Spontaneous migration of common bile duct (CBD) stones occurs in 6-33 % of choledocholithiasis cases, making ERCP avoidable. This study aimed to identify predictors of spontaneous CBD stones' migration.
Retrospective study including patients diagnosed with choledocholithiasis and submitted to ERCP. Patients were divided into 2 groups considering spontaneous stone migration (i.e.: the absence of CBD stones on ERCP). Data on patients' characteristics, imaging findings, biochemical analysis, and ERCP procedure were analyzed to identify predictors of spontaneous migration of CBD stones.
334 patients with a mean age of 71.7 years were included in the study: 76.6 % without and 23.4 % with spontaneous migration of CBD stones. Although some patients' features (gender and clinical presentation), imaging findings (diameters of the largest stone and CBD), biochemical analysis (bilirubin levels at diagnosis and pre-ERCP), and ERCP procedure characteristics (time from diagnosis to ERCP) were different between groups, only three variables were defined as predictors: the absence of acute cholangitis, the largest stone diameter ≤5 mm, and the bilirubin levels pre-ERCP ≤ 2mg/dL. When using those variables together there was a chance of 81-86 % to correctly distinguishing patients with and without spontaneous CBD stone migration.
The size of the largest stone at diagnosis was validated as a predictor of CBD stones' spontaneous migration. Furthermore, two new predictors were identified: bilirubin levels pre-ERCP ≤ 2 mg/dL, and no acute cholangitis at the clinical presentation of choledocholithiasis. EUS and ERCP in the same session should be considered in patients with factors predictive of stone migration, especially when combined, to minimize unnecessary ERCP and possible complications.
内镜逆行胰胆管造影术(ERCP)是治疗胆总管结石的一线手术。然而,它会导致10%的不良事件发生率。6%-33%的胆总管结石病例中会出现胆总管(CBD)结石的自发迁移,从而使ERCP手术可避免。本研究旨在确定CBD结石自发迁移的预测因素。
回顾性研究纳入了被诊断为胆总管结石并接受ERCP手术的患者。根据结石的自发迁移情况(即:ERCP时无CBD结石)将患者分为两组。分析患者特征、影像学检查结果、生化分析和ERCP手术的数据,以确定CBD结石自发迁移的预测因素。
该研究纳入了334例平均年龄为71.7岁的患者:76.6%的患者结石未自发迁移,23.4%的患者结石自发迁移。尽管两组患者的一些特征(性别和临床表现)、影像学检查结果(最大结石直径和CBD直径)、生化分析(诊断时和ERCP前的胆红素水平)以及ERCP手术特征(从诊断到ERCP的时间)有所不同,但只有三个变量被确定为预测因素:无急性胆管炎、最大结石直径≤5mm以及ERCP前胆红素水平≤2mg/dL。当综合使用这些变量时,可以有81%-86%的几率正确区分结石自发迁移和未自发迁移的患者。
诊断时最大结石的大小被证实为CBD结石自发迁移的预测因素。此外,还确定了两个新的预测因素:ERCP前胆红素水平≤2mg/dL以及胆总管结石临床表现时无急性胆管炎。对于有结石迁移预测因素的患者,尤其是综合存在这些因素时,应考虑在同一次手术中进行内镜超声检查(EUS)和ERCP,以尽量减少不必要的ERCP及可能的并发症。